EQS-News: Dermapharm Holding SE
/ Key word(s): Annual Results/Annual Report
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
28.03.2025 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.Read More
You might also be interested in reading Ether ETFs Add $26 Million as Bitcoin’s 7-Day Streak Ends.